Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

Video Highlights: New Data on Weight Gain With ART

July 6-10, 2020; Virtual
Watch this short video highlight to hear expert insights on the latest updates from AIDS 2020: Virtual on weight changes during ART and PrEP.
Jürgen K. Rockstroh, MD
Released: August 17, 2020

Information on this Educational Activity

Faculty

Jürgen K. Rockstroh, MD

Professor of Medicine
University of Bonn
Bonn, Germany

Jürgen K. Rockstroh, MD, has disclosed that he has received consulting fees from Gilead Sciences, Janssen, Merck, Theratechnologies, and ViiV and fees for non-CME/CE services from Gilead Sciences, Janssen, Merck, and ViiV.

Program Medium

This program has been made available online.

Related Content

CCO expert commentary on key studies from HIVR4P // Virtual 2021 on PrEP, implementation strategies, multipurpose prevention technologies, and more

Kenneth Mayer, MD Released: February 25, 2021

Download CCO slides reviewing data and guidelines on management of heavily-treatment experienced patients with HIV experiencing treatment failure

Princy N. Kumar, MD, FIDSA, MACP Brian Wood, MD Released: February 22, 2021

Expert commentary on managing a TB outbreak in a socially and medically complex population of patients living with HIV

Nicky Mehtani, MD, MPH Released: February 22, 2021

CCO video featuring a discussion between Dr. Princy Kumar and Dr. Brian Wood on assessing virologic failure in a heavily treatment-experienced patient

Princy N. Kumar, MD, FIDSA, MACP Brian Wood, MD Physicians: maximum of 0.5 AMA PRA Category 1 Credits Pharmacists: 0.5 contact hours (0.05 CEUs) Released: February 22, 2021 Expired: February 21, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue